Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001214659-20-005496

Director acquired 9,969 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WITTE OWEN N. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-05 Grant or award : show line 1 in the form +9,969 246,151 D
Loading xslF345X03/marketforms-49010.xml…